Presenting Companies

 
News Articles for Presenting Companies top ^
Bristol-Myers Squibb Company (NYSE:BMY) announced today that 16 abstracts for Orencia were accepted for presentation at the 2014 annual meeting of the American College of Rheumatology (ACR) taking place from November 14-19, 2014 in Boston, MA.
Sign-up for Bristol-Myers Squibb to Present Sixteen Orencia (abatacept) Data Abstracts at The American College of Rheumatology (ACR) 2014 Annual Meeting investment picks
2014/11/19
EPIX Presents Road To The NHL Winter Classic™ and EPIX Presents Road To The NHL Stadium Series™ , a two-part original series from premium TV network EPIX and the National Hockey League, will bring U.S. viewers onto the ice and behind-the-scenes with the Chicago Blackhawks and Washington Capitals as they prepare to compete in the 2015 Bridgestone NHL Winter Classic®, and the Los Angeles Kings and San Jose Sharks on their road to the 2015 Coors Light NHL Stadium Series™. EPIX Presents Road To The NHL Winter Classic will make its U.S. Television Premiere on EPIX December 16 at 10pm ET/PT, 9CT with four weekly episodes following the Blackhawks and the Capitals through regular season games as they get ready to face off in the 2015 Bridgestone NHL Winter Classic® outdoor game at Nationals Park in Washington, D.C. on New Year’s Day, January 1.
Sign-up for EPIX Teams with National Hockey League for Two-Part, Eight-Episode Series, EPIX Presents Road To The NHL Winter Classic & EPIX Presents Road To The NHL Stadium Series investment picks
2015/1/12
Athabasca Oil Corporation to Present at Upcoming Industry Conferences and Announces Updated Corporate Presentation Canada NewsWire CALGARY , Jan.
Sign-up for Athabasca Oil Corporation to Present at Upcoming Industry Conferences and Announces Updated Corporate Presentation investment picks
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation CAMBRIDGE, Mass., Nov.
Sign-up for Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting investment picks
Combination of TG-1101, the Company's Novel Glycoenginereed Anti-CD20 Monoclonal Antibody and TGR-1202, the Company's Once Daily PI3K Delta Inhibitor to be Highlighted in Oral Presentation Updates on the Combination of TG-1101 Plus Ibrutinib, and Single-Agent TGR-1202 to be Featured in Poster Presentations TG Therapeutics to Host a Reception on Monday December 8 th from 7:45 pm – 9:00 pm with Presentations by Leading Clinical Investigators NEW YORK, Nov.
Sign-up for TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting investment picks
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty home infusion, and oncology pharmacy services, today announced that David Froesel, Executive Vice President, Chief Financial Officer and Treasurer, will make a presentation regarding the Company at the Credit Suisse 2014 Healthcare Conference in Phoenix, Arizona, on Tuesday, November 11, 2014, at 1:30 p.m. Mountain Time (3:30 p.m. Eastern Time). The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the “For Investors” tab of the Company’s website, www.pharmerica.com , under “Webcasts and Presentations.” In addition, the webcast, transcript and written materials will be archived on the Company’s website following the event.
Sign-up for PharMerica to Present at the Credit Suisse 2014 Healthcare Conference investment picks
Electro Scientific Industries, Inc. (Nasdaq: ESIO), the premier source for innovative laser-based manufacturing solutions for the microtechnology industry, today announced it will be participating at three upcoming investor conferences, including: Sidoti & Company, LLC Emerging Growth Institutional Investor Forum Date: January 12, 2015 Location: Grand Hyatt Hotel in New York City Presentation Time: 10:40 a.m. ET 17 th Annual Needham Growth Conference Date: January 13, 2015 Location: Palace Hotel in New York City Presentation Time: 10:00 a.m. ET Noble Financial Capital Markets’ Eleventh Annual Equity Conference Date: January 20, 2015 Location: Club Med in Sandpiper Bay, Florida Presentation Time: 11:30 a.m. ET The webcast of the Needham and Noble conference presentations will be made
Sign-up for ESI to Present at Three Upcoming Investor Conferences investment picks
--Phase 3 ONTIME Trial Data Selected for Oral Presentation--
Sign-up for Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting investment picks
2014/11/3
Subhead of release should read: Presentation to be Webcast Live at 1:00 p.m. ET on November 11 (instead of Presentation to be Webcast Live at 12:00 p.m. ET on November 11). Second paragraph, first sentence of release should read: The Company’s presentation will be webcast live at 1:00 p.m. ET on Tuesday, November 11.
Sign-up for CORRECTING and REPLACING CIRCOR International to Present at Baird’s 2014 Industrial Conference investment picks
Pfizer Inc. announced today that it will present data for several of its marketed and investigational medicines for inflammatory and immunological conditions at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2014 Annual Meeting (November 14-19, Boston, Massachusetts). Twenty-one abstracts for XELJANZ ® (tofacitinib citrate) will be presented, including the six-year safety and efficacy analyses from long-term extension (LTE) studies and a summary of real-world patient experience, additional post-hoc analyses from the clinical development program, and health and economics outcomes research, adding to the substantial body of evidence for XELJANZ as an oral treatment option for moderate to severe rheumatoid arthritis (RA). Data will also be presented for several additional Pfizer assets, including PF-04236921, an investigational
Sign-up for Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting investment picks
Demandware ®, Inc. (NYSE:DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conferences: Barclays Global Technology Conference Tom Ebling, Demandware Chief Executive Officer, will present on Tuesday, December 9 th at 9:20 a.m. PST at The Palace Hotel, San Francisco, CA BMO Capital Markets 2014 Technology & Digital Media Conference Tim Adams, Demandware Chief Financial Officer, will present on Wednesday, December 10 th at 9:00 a.m. EST at The Grand Hyatt New York, New York An audio webcast of the presentations will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executives to Present at Upcoming Investor Conferences investment picks
- Addition of Lollapalooza and Austin City Limits to Festival Portfolio - LOS ANGELES and AUSTIN, Texas , Dec 19, 2014 /PRNewswire/ -- Live Nation Entertainment (NYSE: LYV) announced today the completion of a transaction to acquire a controlling stake in C3 Presents.
Sign-up for Live Nation Entertainment Expands Festival Portfolio With C3 Presents investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G031000-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/21/11G031000/20130207-eca_200-473944305185.jpg CALGARY, AB--(Marketwired - January 21, 2015) - Encana Corporation (TSX: ECA) (NYSE: ECA) Michael McAllister, Executive Vice-President and Chief Operating Officer, will be presenting at the CIBC 18 th Annual Whistler Institutional Investor Conference on Thursday, January 22, 2015 at approximately 10:00 a.m. PT (11:00 a.m. MT) in Whistler, B.C. Links to the audiocast and presentation slides will be available at the start of the presentation on Encana's website, www.encana.com , under Invest in Us/Presentations & Events, or via the following URL: Webcast link: https://webcasts.welcome2theshow.com/cibcwhistler2015 Encana Corporation Encana is a leading North American energy producer that is
Sign-up for Encana to Present at the CIBC 18th Annual Whistler Institutional Investor Conference investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in November and December, data will be presented for the first time investigating the use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in advanced melanoma in comparison to chemotherapy, and in relapsed/refractory classical Hodgkin Lymphoma (cHL) as well as advanced triple negative breast cancer (TNBC). These studies will be presented in oral sessions at the Society for Melanoma Research (SMR) 2014 International Congress, Nov.
Sign-up for New Studies Investigating the Use of KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Advanced Melanoma Compared to Chemotherapy, in Classical Hodgkin Lymphoma and in Triple Negative Breast Cancer, to be Presented for the First Time investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that data from its ongoing Phase 1/2 HGB-205 and Northstar Studies of LentiGlobin BB305 Drug Product will be presented at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place December 6 – 9, 2014 in San Francisco, California.
Sign-up for bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference investment picks
Intevac, Inc. (Nasdaq: IVAC) announced today that company management is scheduled to participate in the following investor event: Needham Next-Gen Storage / Networking Conference Le Parker Meridien Hotel, New York, NY Date: Tuesday, November 11th, 2014 Presentation time: 9:00am EST The presentation webcast and slides will be available through the presentations link on the investor page of the company’s website for a limited time.
Sign-up for Intevac to Present at the Needham Next-Gen Storage and Networking Conference investment picks
A late-breaking poster presentation focused on five-year vision data from Lundbeck’s SABRIL (vigabatrin) patient registry was presented at the annual meeting of the American Epilepsy Society (AES). The data set includes 6,823 patients enrolled from August 21, 2009 through August 26, 2014.
Sign-up for Five-Year Data From SABRIL® (vigabatrin) Registry Presented at American Epilepsy Society Annual Meeting investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 33 rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 12:30 p.m. ET (9:30 a.m. PT). The audio portion of management’s remarks may be accessed live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” page.
Sign-up for Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Presenting Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Presented Results  |  Next: Preserve Assets